Xyotax demonstrates ability to control disease in chemotherapy-resistant cancer patients July 1, 2002
Enrollment completed in phase II trial of tesmilifene combination therapy in prostate cancer June 27, 2002
Preclinical and early clinical findings for TAK-013, a potent oral GnRH receptor antagonist June 27, 2002
RSS